Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 91 | 26 | 65 |
| Samples | 90 | 26 | 64 |
| Peptides | 54 | 14 | 42 |
Function
CSF2 · Colony stimulating factor 2
The protein encoded by this gene is a cytokine that controls the production, differentiation, and function of granulocytes and macrophages. The active form of the protein is found extracellularly as a homodimer. This gene has been localized to a cluster of related genes at chromosome region 5q31, which is known to be associated with interstitial deletions in the 5q- syndrome and acute myelogenous leukemia. Other genes in the cluster include those encoding interleukins 4, 5, and 13. This gene plays a role in promoting tissue inflammation. Elevated levels of cytokines, including the one produced by this gene, have been detected in SARS-CoV-2 infected patients that develop acute respiratory distress syndrome. Mice deficient in this gene or its receptor develop pulmonary alveolar proteinosis. [provided by RefSeq, Aug 2020].
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000296871 | P04141 | 91 | 54 |
Gene Properties
Recurrent Mutations
All 54 amino-acid changes on canonical ENST00000296871 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in CSF2 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in CSF2 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 3/40 8% | 0/0 0% |
| Rhabdomyosarcoma | 0/33 0% | 5/171 3% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 3/133 2% |
| Meningioma | 0/3 0% | 3/252 1% |
| Neuroendocrine Tumour | 6/154 4% | 1/577 0% |
| Ewings Sarcoma | 2/63 3% | 0/262 0% |
| Melanoma | 2/210 1% | 9/1899 0% |
| Bladder Carcinoma | 0/58 0% | 5/956 1% |
| Squamous Cell Lung Carcinoma | 1/57 2% | 3/810 0% |
| Other Solid Cancers | 2/94 2% | 4/1515 0% |
| Thyroid Gland Carcinoma | 0/45 0% | 6/1592 0% |
| Ovarian Carcinoma | 3/109 3% | 1/998 0% |
| Endometrial Carcinoma | 0/42 0% | 2/612 0% |
| Non-Small Cell Lung Carcinoma | 4/304 1% | 1/1390 0% |
| Colorectal Carcinoma | 3/143 2% | 5/3239 0% |
| Cervical Carcinoma | 0/35 0% | 1/422 0% |
| Esophageal Carcinoma | 0/23 0% | 1/769 0% |
| Other Sarcomas | 0/69 0% | 1/699 0% |
| Gastric Carcinoma | 0/74 0% | 2/1809 0% |
| Non-Cancerous | 0/104 0% | 1/830 0% |
| Glioma | 0/52 0% | 2/2127 0% |
| B-Cell Non-Hodgkins Lymphoma | 0/88 0% | 2/2534 0% |
| Other Blood Cancers | 0/61 0% | 2/2725 0% |
| Pancreatic Carcinoma | 0/89 0% | 1/1611 0% |
| Breast Carcinoma | 0/144 0% | 2/3264 0% |
| Prostate Carcinoma | 0/13 0% | 1/2105 0% |
Mutation Distribution
Where CSF2 is mutated · all tissues, split by cell line vs tissue
How many mutations in CSF2 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 7 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 91 mutations in CSF2
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|